Placental growth factor as a target for the treatment of osteoporosis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 15, 2008
Grant Date -
Aug 11, 2005
app pub date -
Jun 27, 2003
filing date -
Jun 28, 2002
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This invention relates to antagonists of placental growth factor and signalling thereof, pharmaceutical compositions containing such antagonists and the use of such antagonists to prevent bone loss or bone mass and to enhance bone healing including the treatment of conditions which present with low bone mass and/or bone defects in vertebrates, and particularly mammals, including humans.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully